Researchers Identify Western Finland Region as Potential Sixth 'Blue Zone'

A team of researchers is proposing that Ostrobothnia, a bilingual region on Finland’s west coast, be considered a potential new "Blue Zone" after preliminary analyses indicated an unusually high life expectancy among its residents.

Blue Zones are regions where people live longer than average and often reach 100 years of age at higher rates. The designation has drawn attention from health researchers and lifestyle advocates worldwide; the five widely cited Blue Zones include Ikaria in Greece and Okinawa in Japan. The research team, led by Sarah Åkerman, a social policy researcher at Åbo Akademi University in Finland, assessed three Finnish regions and singled out Ostrobothnia for its striking longevity figures.

"Ostrobothnia might be deemed a potential longevous Blue Zone," the researchers wrote, while emphasizing that "future rigorous demographic research is needed in order to validate exceptional longevity in this region." Their description characterizes the region’s life expectancy as "extraordinary," but the team did not present definitive population-level confirmation in the initial report.

Blue Zone designations typically reflect sustained patterns of lower mortality, higher proportions of centenarians and consistent lifestyle or environmental factors that support long life, such as diet, physical activity, strong social networks and low stress. The researchers point to several local features in Ostrobothnia that may contribute to longer lives, including lifestyle and community attributes historically linked to longevity.

The study examined mortality and longevity indicators across three Finnish regions and found Ostrobothnia stood out in ways the researchers described as comparable to established Blue Zones. The report does not yet provide detailed demographic breakdowns or peer-reviewed population-level analyses that would be required to confirm a Blue Zone designation under the standards used by other longevity researchers.

Scientific interest in Blue Zones has grown as public health experts probe which community-level factors can be adapted to other populations. Prior Blue Zone research has combined demographic analysis with ethnographic and lifestyle study to identify recurring elements such as predominantly plant-forward diets, habitual physical movement in daily life, intergenerational social ties and stress-moderating cultural practices.

Åkerman and colleagues recommend more rigorous demographic work to verify whether Ostrobothnia’s observed longevity is exceptional by global standards and persistent across cohorts. Such work would typically include longitudinal analyses, age-validation of centenarian counts, and control for migration and socioeconomic variables that can influence regional life expectancy statistics.

If further research confirms Ostrobothnia’s exceptional longevity, the finding would expand the geographic and cultural contexts in which prolonged life spans have been documented and may offer new angles for public health strategies focused on community-level interventions. For now, the region remains a candidate rather than an officially recognized Blue Zone, and researchers caution against premature generalization of the initial findings.

The proposal adds to ongoing efforts in gerontology and population health to identify environmental and social determinants of long life that can be reliably measured and, where appropriate, applied to improve health outcomes in other settings.